参考文献/References:
[1] Palu RA, Thummel CS. Sir2 acts through hepatocyte nuclear factor 4 to maintain insulin signaling and metabolic homeostasis in drosophila[J].PLoS Genet,2016,12(4):e1005978. DOI:10.1371/journal.pgen.1005978.
[2] Meng X, Tan J, Li M, et al. Sirt1: role under the condition of ischemia/hypoxia[J].Cell Mol Neurobiol,2017,37(1):17-28. DOI:10.1007/s10571-016-0355-2.
[3] Zhang ZH, Su PY, Hao JH, et al. The role of preexisting diabetes mellitus on incidence and mortality of endometrial cancer: a meta-analysis of prospective cohort studies[J].Int J Gynecol Cancer,2013,23(2):294-303.DOI:10.1097/IGC.0b013e31827b8430.
[4] Fang H, Yao B, Yan Y,et al. Diabetes mellitus increases the risk of bladder cancer: an updated meta-analysis of observational studies[J].Diabetes Technol Ther,2013,15(11):914-922.DOI:10.1089/dia.2013.0131.
[5] Toriola AT, Stolzenberg-Solomon R, Dalidowitz L, et al. Diabetes and pancreatic cancer survival: a prospective cohort-based study[J].Br J Cancer,2014,111(1):181-185. DOI:10.1038/bjc.2014.224.
[6] Meyerhardt JA, Catalano PJ, Haller DG, et al. Impact of diabetes mellitus on outcomes in patients with colon cancer[J]. J Clin Oncol,2003,21(3):433-440.DOI:10.1200/jco.2003.07.125.
[7] Wang RH, Zheng Y, Kim HS,et al. Interplay among BRCA1, SIRT1, and Survivin during BRCA1-associated tumorigenesis[J]. Mol Cell,2008,32(1):11-20. DOI:10.1016/j.molcel.2008.09.011.
[8] Howitz KT, Bitterman KJ, Cohen HY, et al.Small molecule activators of sirtuins extend Saccharomyces cerevisiae life span[J].Nature,2003,425(6954):191-196.DOI:10.1038/nature 01960.
[9] Brighton CA, Rievaj J, Kuhre RE, et al. Bile acids trigger GLP-1 release predominantly by accessing basolaterally located G protein-coupled bile acid receptors[J].Endocrinology,2015,156(11):3961-3970. DOI:10.1210/en.2015-1321.
[10] Kabra N, Li Z, Chen L,et al. SirT1 is an inhibitor of proliferation and tumor formation in colon cancer[J].J Biol Chem,2009,284(27):18210-18217. DOI:10.1074/jbc.M109.000034.
[11] Benard A, Goossens-Beumer IJ, van Hoesel AQ, et al. Nuclear expression of histone deacetylases and their histone modifications predicts clinicaloutcome in colorectal cancer[J].Histopathology,2015,66(2):270-282. DOI:10.1111/his.12534.
[12] Di Sante G, Pestell TG, Casimiro MC,et al. Loss of Sirt1 promotes prostatic intraepithelial neoplasia, reduces mitophagy, and delays PARK2 translocation to mitochondria[J].Am J Pathol,2015,185(1):266-279. DOI:10.1016/j.ajpath.2014.09.014.
[13] Jang SH, Min KW, Paik SS,et al. Loss of SIRT1 histone deacetylase expression associates with tumour progression in colorectaladenocarcinoma[J].J Clin Pathol,2012,65(8):735-739. DOI:10.1136/jclinpath-2012-200685.
[14] Herranz D, Mun`oz-Martin M, Can`amero M,et al. Sirt1 improves healthy ageing and protects from metabolic syndrome-associated cancer[J].Nat Commun,2010,1:3.DOI:10.1038/ncomms1001.
[15] Cho IR, Koh SS, Malilas W,et al. SIRT1 inhibits proliferation of pancreatic cancer cells expressing pancreatic adenocarcinoma up-regulated factor(PAUF), a novel oncogene, by suppression of β-catenin[J].Biochem Biophys Res Commun,2012,423(2):270-275. DOI:10.1016/j.bbrc.2012.05.107.
[16] Dabrowski M, Szymańska-Garbacz E, Miszczyszyn Z,et al. Risk factors for cancer development in type 2 diabetes: a retrospective case-control study[J].BMC Cancer,2016,16(1):785.DOI:10.1186/s12885-016-2836-6.
[17] Ye X, Li M, Hou T, et al. Sirtuins in glucose and lipid metabolism[J].Oncotarget,2017,8(1):1845-1859. DOI:10.18632/oncotarget.12157.
[18] Kitada M, Kume S, Kanasaki K, et al. Sirtuins as possible drug targets in type 2 diabetes[J]. Curr Drug Targets,2013,14(6):622-636.
[19] Sun W, Lu J, Wu S,et al. Association of insulin resistance with breast, ovarian, endometrial and cervical cancers in non-diabetic women[J].Am J Cancer Res,2016,6(10):2334-2344.
[20] 张果,李小平,王建六,等.子宫内膜癌细胞和组织中胰岛素受体亚型的表达及作用的初步探讨[J].中华妇产科杂志,2012,47(11):839-845.DOI:10.3760/cma.j.issn.0529-567x.2012.11.009.
[21] 余娇娇, 花芳, 胡卓伟.糖尿病促进肿瘤发生发展的研究进展[J].药学学报, 2016, 51(7): 1017-1024.DOI:10.16438/j.0513-4870.2016_0254.
[22] Cao Y, Jiang X, Ma H,et al. SIRT1 and insulin resistance[J].J Diabetes Complications,2016,30(1):178-183.DOI:10.1016/j.jdiacomp.2015.08.022.
[23] Cöté CD, Rasmussen BA, Duca FA, et al. Resveratrol activates duodenal Sirt1 to reverse insulin resistance in rats through a neuronal network[J].Nat Med,2015,21(5):498-505. DOI:10.1038/nm.3821.
[24] Yang P, Guo L, Duan ZJ,et al. Histone methyltransferase NSD2/MMSET mediates constitutive NF-κB signaling for cancer cell proliferation, survival, and tumor growth via a feed-forward loop[J].Mol Cell Biol,2012,32(15):3121-3131. DOI:10.1128/MCB.00204-12.
[25] Yang Q, Wang B, Gao W, et al. SIRT1 is downregulated in gastric cancer and leads to G1-phase arrest via NF-κB/cyclin d1signaling[J].Mol Cancer Res,2013,11(12):1497-1507. DOI:10.1158/1541-7786.MCR-13-0214.
[26] Jiang K, Lyu L, Shen Z, et al. Overexpression of SIRT1 is a poor prognostic factor for advanced colorectal cancer[J].Chin Med J(Engl),2014,127(11):2021-2024.
相似文献/References:
[1]赵紫琴,雒瑢,田凤石,等.替米沙坦对OLETF大鼠皮下和内脏脂肪组织PPARγ表达的影响[J].国际内分泌代谢杂志,2014,(06):365.[doi:10.3760/cma.j.issn.1673-4157.2014.06.002]
Zhao Ziqin*,Luo Rong,Tian Fengshi,et al.Effects of telmisartan on expression of PPARγ in subcutaneous and visceral adipose tissue in OLETF rats[J].International Journal of Endocrinology and Metabolism,2014,(06):365.[doi:10.3760/cma.j.issn.1673-4157.2014.06.002]
[2]姚霜霜,张翼飞,张志国,等.小檗碱改善代谢性疾病的肠道相关机制[J].国际内分泌代谢杂志,2014,(06):386.[doi:10.3760/cma.j.issn.1673-4157.2014.06.007]
Yao Shuangshuang,Zhang Yifei,Zhang Zhiguo,et al.The gut-related mechanisms of berberine in the treatment of metabolic diseases[J].International Journal of Endocrinology and Metabolism,2014,(06):386.[doi:10.3760/cma.j.issn.1673-4157.2014.06.007]
[3]曹萌 韦晓 刘超.自噬与胰岛β细胞功能及2型糖尿病[J].国际内分泌代谢杂志,2015,(01):53.[doi:10.3760/cma.j.issn.1673-4157.2015.01.013]
Cao Meng,Wei Xiao,Liu Chao..Relationship between autophagy and islet β cells function, type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2015,(06):53.[doi:10.3760/cma.j.issn.1673-4157.2015.01.013]
[4]刘艳 田秀标 韩颖.GLP-1受体激动剂呈葡萄糖依赖性刺激胰岛β细胞胰岛素分泌的机制[J].国际内分泌代谢杂志,2015,(01):66.[doi:10.3760/cma.j.issn.1673-4157.2015.01.017]
Liu Yan*,Tian Xiubiao,Han Ying..Mechanism of GLP-1 receptor agonists in the stimulation of insulin secretion of islet β cell in a glucose-dependent manner[J].International Journal of Endocrinology and Metabolism,2015,(06):66.[doi:10.3760/cma.j.issn.1673-4157.2015.01.017]
[5]齐利琴,刘礼斌.GLP-1在2型糖尿病诱发的阿尔茨海默病治疗中的作用[J].国际内分泌代谢杂志,2016,36(01):48.[doi:10.3760/cma.j.issn.1673-4157.2016.01.012]
Qi Liqin,Liu Libin..Effects of GLP-1 in the treatment of Alzheimer's disease induced by type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2016,36(06):48.[doi:10.3760/cma.j.issn.1673-4157.2016.01.012]
[6]梅稳,向光大,卢俊颜,等.GDF11对ApoE-/-糖尿病小鼠内皮依赖性
血管舒张功能的作用[J].国际内分泌代谢杂志,2016,36(02):101.[doi:10.3760/cma.j.issn.1673-4157.2016.02.007]
Mei Wen*,Xiang Guangda,Lu Junyan,et al.Effects of GDF11 on endothelium-dependent vasodiation function of aorta in ApoE-/- diabetic mice[J].International Journal of Endocrinology and Metabolism,2016,36(06):101.[doi:10.3760/cma.j.issn.1673-4157.2016.02.007]
[7]殷俏,张云良,郭淑芹,等.视黄醇结合蛋白4、超敏C反应蛋白
与糖尿病视网膜病变的关系[J].国际内分泌代谢杂志,2016,36(03):149.[doi:10.3760/cma.j.issn.1673-4157.2016.03.02]
Yin Qiao,Zhang Yunliang,Guo Shuqin,et al.Relationship of retinol binding protein 4 and high sensitive C-reactive protein with diabetic retinopathy[J].International Journal of Endocrinology and Metabolism,2016,36(06):149.[doi:10.3760/cma.j.issn.1673-4157.2016.03.02]
[8]王涛,张洁,祁范范,等.不同糖耐量人群血清25(OH)D3水平
及与胰岛β细胞功能的关系[J].国际内分泌代谢杂志,2016,36(04):226.[doi:10.3760/cma.j.issn.1673-4157.2016.04.04]
Wang Tao*,Zhang Jie,Qi Fanfan,et al.Relationship between serum 25(OH)D3 level and islet β cell function in individuals with different glucose tolerance[J].International Journal of Endocrinology and Metabolism,2016,36(06):226.[doi:10.3760/cma.j.issn.1673-4157.2016.04.04]
[9]陈双双,王楚媛,孔令芳.铬与2型糖尿病[J].国际内分泌代谢杂志,2016,36(04):272.[doi:10.3760/cma.j.issn.1673-4157.2016.04.13]
Chen Shuangshuang,Wang Chuyuan,Kong Lingfang.Chromium and type 2 diabetes[J].International Journal of Endocrinology and Metabolism,2016,36(06):272.[doi:10.3760/cma.j.issn.1673-4157.2016.04.13]
[10]涂萍,许婷,段鹏,等.25-羟维生素D3补充对绝经后2型糖尿病
患者胰岛素敏感性及血糖控制的影响[J].国际内分泌代谢杂志,2016,36(05):299.[doi:10.3760/cma.j.issn.1673-4157.2016.05.04]
Tu Ping,Xu Ting,Duan Peng,et al.Influence of 25-hydroxyvitamin D3 supplement on insulin sensitivity and glucose control in postmenopausal patients with type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2016,36(06):299.[doi:10.3760/cma.j.issn.1673-4157.2016.05.04]